Arnon Nagler – Allo-transplant for AML: what’s new at EHA 2021
By Adam Barkay|2021-06-22T13:48:20+00:00June 22nd, 2021|All, EHA 2021|Comments Off on Arnon Nagler – Allo-transplant for AML: what’s new at EHA 2021
About the Author: Adam Barkay
Related Posts
Nov 28th 2023- Prof. Ibrahim Yakoub-Agha- Nonrelapse Mortality After CAR T-cell Therapy for Large B-cell Lymphoma: a LYSA Study from the DESCAR-T Registry
Nov 28th 2023- Prof. Ibrahim Yakoub-Agha- Nonrelapse Mortality After CAR T-cell Therapy for Large B-cell Lymphoma: a LYSA Study from the DESCAR-T Registry
Nov 21st 2023- Prof. Moshe Mittelman- A Randomized Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial